Literature DB >> 27329150

MAL and TMEM220 are novel DNA methylation markers in human gastric cancer.

Boram Choi1, Tae-Su Han2, Jimin Min3, Keun Hur3, Sun-Min Lee4, Hyuk-Joon Lee1,5, Young-Joon Kim5, Han-Kwang Yang1,6.   

Abstract

CONTEXT: Gastric cancer (GC) is the fourth most common cause of cancer-related deaths worldwide.
OBJECTIVE: To determine the mRNA-expression of the MAL, TMEM220, MMP28, IL-19 and HOPX genes and analyse the methylation statuses of MAL and TMEM220.
MATERIALS AND METHODS: Gene-expression levels were analysed in 10 GC cell lines and 30 matched pairs of GC and normal mucosa (NM) gastric tissue specimens in real-time reverse-transcriptase polymerase chain reactions. Gene methylation was evaluated by bisulphite sequencing. Detailed gene-methylation patterns were confirmed by pyrosequencing analysis.
RESULTS: MAL, TMEM220, MMP28 and IL-19 were significantly down-regulated in GC cell lines and GC tissues compared to NM tissues. MAL and TMEM220 were highly methylated in GC tissues, and methylation inversely correlated with expression. MAL and TMEM220 expression were restored by treatment with 5-aza-2'-deoxycytidine. MAL and TMEM220 were specifically methylated and were down-regulated in human GC. DISCUSSION AND
CONCLUSION: These loci may serve as novel methylation markers for patients with GC.

Entities:  

Keywords:  Biomarker; HOPX; IL-19; MMP28; T-cell differentiation protein; gastric cancer methylation

Mesh:

Substances:

Year:  2016        PMID: 27329150     DOI: 10.1080/1354750X.2016.1201542

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  10 in total

Review 1.  The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.

Authors:  Armando Rubio-Ramos; Leticia Labat-de-Hoz; Isabel Correas; Miguel A Alonso
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

2.  Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies.

Authors:  Eleonora Zorzan; Ramy Elgendy; Giorgia Guerra; Silvia Da Ros; Maria Elena Gelain; Federico Bonsembiante; Giulia Garaffo; Nicoletta Vitale; Roberto Piva; Laura Marconato; Luca Aresu; Mauro Dacasto; Mery Giantin
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

3.  The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer.

Authors:  Haochang Hu; Xiaoying Chen; Cheng Wang; Yuting Jiang; Jingjing Li; Xiuru Ying; Yong Yang; Bin Li; Cong Zhou; Jie Zhong; Dongping Wu; Jieer Ying; Shiwei Duan
Journal:  Oncotarget       Date:  2017-09-20

4.  Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study.

Authors:  JinHui Liu; Mingming Feng; SiYue Li; Sipei Nie; Hui Wang; Shan Wu; Jiangnan Qiu; Jie Zhang; WenJun Cheng
Journal:  Cancer Cell Int       Date:  2020-02-19       Impact factor: 5.722

5.  The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma.

Authors:  Shiming Yang; Yaping Zhou; Xiangxin Zhang; Lu Wang; Jianfeng Fu; Xiaotong Zhao; Liu Yang
Journal:  BMC Bioinformatics       Date:  2021-04-28       Impact factor: 3.169

6.  Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma.

Authors:  Dong Li; Juan Zhang; Lilong Wu; Xiaoming Yang; Zheng Chen; Jiangjing Yuan
Journal:  Cancer Manag Res       Date:  2021-09-21       Impact factor: 3.989

7.  MAL protein suppresses the metastasis and invasion of GC cells by interfering with the phosphorylation of STAT3.

Authors:  Zhijun Geng; Jing Li; Sandang Li; Yueyue Wang; Lele Zhang; Qiuzi Hu; Xinru Wang; Lugen Zuo; Xue Song; Xiaofeng Zhang; Sitang Ge; Jianguo Hu
Journal:  J Transl Med       Date:  2022-01-29       Impact factor: 5.531

8.  Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma.

Authors:  Zhonghao Wang; Qian Wu; Shu Feng; Yanhua Zhao; Chuanmin Tao
Journal:  PeerJ       Date:  2017-07-18       Impact factor: 2.984

Review 9.  The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting.

Authors:  Luciano Pirola; Oskar Ciesielski; Aneta Balcerczyk
Journal:  Cancers (Basel)       Date:  2018-08-10       Impact factor: 6.639

10.  DNA hypermethylation of MAL gene may act as an independent predictor of favorable prognosis in patients with colorectal cancer.

Authors:  Xinyan Liu; Haoran Bi; Anqi Ge; Tingting Xia; Jinming Fu; Yupeng Liu; Hongru Sun; Dapeng Li; Yashuang Zhao
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.